Quick Answer
Zepp Health Corp reported Cash and Equivalents of $91.07 million for fiscal year 2024.
Zepp Health Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $91.07M | -31.9% |
| 2023 | $133.67M | +4.0% |
| 2022 | $128.55M | -91.2% |
| 2021 | $1.47B | -35.4% |
| 2020 | $2.27B | +26.1% |
| 2019 | $1.80B | +25.1% |
| 2018 | $1.44B | +293.6% |
| 2017 | $366.34M | +139.2% |
| 2016 | $153.15M | — |
- Zepp Health Corp showed a decrease of -31.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2016–2024 period, Zepp Health Corp’s cash and equivalents has declined by 40.5% (from $153.15 million to $91.07 million).
- The most recent figure is from Zepp Health Corp’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: